Mesenchymal stem cells and alginate microcarriers for craniofacial bone tissue engineering: A review.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26826060.
- Also identified by DOI 10.1002/jbm.a.35647.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Craniofacial bone is a complex structure with an intricate anatomical and physiological architecture. The defects that exist in this region therefore require a precise control of osteogenesis in their reconstruction. Unlike traditional surgical intervention, tissue engineering techniques mediate bone development with limited postoperative risk and cost. Alginate stands as the premier polymer in bone repair because of its mild ionotropic gelation and excellent biocompatibility, biodegradability, and injectability. Alginate microcarriers are candidates of choice to mediate cells and accommodate into 3-D environment. Several studies reported the use of alginate microcarriers for delivering cells, drugs, and growth factors. This review will explore the potential use of alginate microcarrier for stem cell systems and its application in craniofacial bone tissue engineering.
Medical subject headings
- Alginates
- Bone Substitutes
- Facial Bones
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells
- Skull
- Tissue Engineering